Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Lack of effectiveness of 13-valent pneumococcal conjugate vaccination against pneumococcal carriage density in Papua New Guinean infants

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Publication Information:
      Elsevier Ltd
    • Publication Date:
      2021
    • Collection:
      Federation University Australia: FedUni ResearchOnline
    • Abstract:
      Background: Papua New Guinea (PNG) introduced the 13-valent pneumococcal conjugate vaccine (PCV13) in 2014, with administration at 1, 2, and 3 months of age. PCV13 has reduced or eliminated carriage of vaccine types in populations with low pneumococcal carriage prevalence, carriage density and serotype diversity. This study investigated PCV13 impact on serotype-specific pneumococcal carriage prevalence, density, and serotype diversity in PNG infants, who have some of the highest reported rates of pneumococcal carriage and disease in the world. Methods: Nasopharyngeal swabs were collected at 1, 4 and 9 months of age from PCV13-vaccinated infants (n = 57) and age-/season-matched, unvaccinated infants (at approximately 1 month, n = 53; 4 months, n = 57; 9 months, n = 52). Serotype-specific pneumococcal carriage density and antimicrobial resistance genes were identified by qPCR and microarray. Results: Pneumococci were present in 89% of swabs, with 60 different serotypes and four non-encapsulated variants detected. Multiple serotype carriage was common (47% of swabs). Vaccine type carriage prevalence was similar between PCV13-vaccinated and unvaccinated infants at 4 and 9 months of age. The prevalence of non-vaccine type carriage was also similar between cohorts, with non-vaccine types present in three-quarters of samples (from both vaccinated and unvaccinated infants) by 4 months of age. The median pneumococcal carriage density was high and similar at each age group (~7.0 log10 genome equivalents/mL). PCV13 had no effect on overall pneumococcal carriage density, vaccine type density, non-vaccine type density, or the prevalence of antimicrobial resistance genes. Conclusion: PNG infants experience dense and diverse pneumococcal colonisation with concurrent serotypes from 1 month of age. PCV13 had no impact on pneumococcal carriage density, even for vaccine serotypes. The low prevalence of vaccine serotypes, high pneumococcal carriage density and abundance of non-vaccine serotypes likely contribute to the lack of ...
    • Relation:
      Vaccine Vol. 39, no. 38 (2021), p. 5401-5409; http://researchonline.federation.edu.au/vital/access/HandleResolver/1959.17/179570; vital:15610; https://doi.org/10.1016/j.vaccine.2021.07.085
    • Accession Number:
      10.1016/j.vaccine.2021.07.085
    • Online Access:
      http://researchonline.federation.edu.au/vital/access/HandleResolver/1959.17/179570
      https://doi.org/10.1016/j.vaccine.2021.07.085
    • Rights:
      All metadata describing materials held in, or linked to, the repository is freely available under a CC0 licence ; http://creativecommons.org/licenses/by/4.0/ ; Copyright © 2021 The Authors. Published by Elsevier Ltd. ; Open Access
    • Accession Number:
      edsbas.E93742CF